1) Goldman M, Dequardo JR, Tandon R et al: Symptom correlates of global measures of severity in schizophrenia. Compr. Psychiatry 40: 458461, 1999.
2) Guy W: ECDEU Assessment Manual for Psychopharmacology. Department of Health, Education and Welfare Publications, Rockville, MD, pp. 218-222, 1976.
3) Kerwin R, Millet B, Herman E et al: A multicentre, randomized naturalistic, open-label study between aripiprazole and standard of care in the manage-ment of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole Europian Psychiatry, 22:433-443, 2007.
4) Tandon R, Drvrllis RF, Han J et al: Validation of the Investigator's Assessment Questionnaire, a new clinical tool for relative assessment of response to antipsychotics in patients with schizophrenia and schizoaffective disorder. Psychiatry Res, 136: 211-221, 2005.